B-NATAL LOZENGE OTC
Generic Name and Formulations:
Pyridoxine 25mg; lozenge; green apple flavor.
Everidis Health Sciences
Indications for B-NATAL LOZENGE:
Reduce severity of nausea and hyperemesis gravidarum in pregnancy.
1 TheraPop or lozenge every 8 hrs; max 3 doses per day.
May antagonize phenytoin, phenobarbital, levodopa. Antagonized by isoniazid, cycloserine, penicillamine, levodopa, alcohol.
GI upset, abdominal pain, loss of appetite, breast soreness with high doses (>200mg/day) .
Clinical Pain Advisor Articles
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis